Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zishui Daohuo is a Traditional Chinese Medicine (TCM) formula primarily used to treat symptoms associated with Yin deficiency and hyperactive fire, most notably perimenopausal syndrome and chronic insomnia. The formula typically comprises several herbal ingredients, including *Rehmannia glutinosa*, *Scrophularia ningpoensis*, *Ophiopogon japonicus*, *Phellodendron amurense*, and *Anemarrhena asphodeloides*. Its mechanism of action involves nourishing the Kidney Yin and sedating Heart fire, which translates in modern pharmacological terms to the modulation of the hypothalamic-pituitary-ovarian (HPO) axis and the regulation of neurotransmitters such as serotonin and GABA. It is widely utilized in China as an alternative or complementary therapy to hormone replacement therapy (HRT) for managing hot flashes, night sweats, and emotional instability during menopause.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zishui Daohuo.